S&P Futures
4,021.00 +19.50 (+0.49%) Dow Futures
32,716.00 +128.00 (+0.39%) Nasdaq Futures
12,786.00 +53.50 (+0.42%) Russell 2000 Futures
1,776.70 +11.90 (+0.67%) Crude Oil
73.58 +0.38 (+0.52%) Gold
1,967.80 -5.70 (-0.29%)
enVVeno Medical Corporation (5HJ.F)
- ACCESSWIRE
enVVeno Medical Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Corporate Update
enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of venous disease, today provided a corporate update and reported financial results for the fourth quarter and year-end of 2022.
- ACCESSWIRE
enVVeno Medical to Present at Cowen's 43rd Annual Health Care Conference
/ enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of venous disease, today announced that Robert Berman, CEO of enVVeno Medical, will present at Cowen's 43rd Annual Health Care Conference on Wednesday, March 8, 2023 at 9:10 AM ET.
- ACCESSWIRE
enVVeno Medical Promotes Dr. Hamed Alavi to Senior Vice President and Chief Technology Officer
enVVeno Medical Corporation (Nasdaq:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of venous disease, today announced the promotion of Dr. Hamed Alavi to Senior Vice President and Chief Technology Officer.
